Optiver Holding
HUMA icon

Optiver Holding’s Humacyte HUMA Stock Holding History

Optiver Holding’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443 Sell
731
-98
-12% -$102 ﹤0.01% 2176
2025
Q4 		$796 Sell
829
-109
-12% -$154 ﹤0.01% 2240
2025
Q3 		$1.63K Buy
+938
New +$1.84K ﹤0.01% 2431

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Optiver Holding's HUMA Position: Q1 2026 in Review

Optiver Holding reduced its Humacyte (HUMA) stake by 12% in Q1 2026, selling an estimated $102 and leaving 731 shares worth $443. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Optiver Holding first reported a position in HUMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.63K in Q3 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Optiver Holding held 731 shares of Humacyte worth $443 as of Q1 2026.
  • Optiver Holding sold 98 Humacyte shares in Q1 2026, an estimated $102.
  • Humacyte made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2176 holding.
  • Optiver Holding first reported a position in Humacyte in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Humacyte position peaked at $1.63K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.